1
|
Kumar P, Thota PN. Barrett's Esophagus in Rubinstein-Taybi Syndrome. Cureus 2020; 12:e11709. [PMID: 33391942 PMCID: PMC7769793 DOI: 10.7759/cureus.11709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Rubinstein-Taybi syndrome (RSTS; Online Mendelian Inheritance in Man® [OMIM®] #180849, #613684; Orpha: 783 ) is a rare plurimalformative autosomal dominant genetic disorder that affects one in 100,000-125,000 newborns with equal male and female distribution. It is characterized by distinctive facial features, short stature, broad and often angulated thumbs and halluces, and moderate-to-severe intellectual disability. In addition to ocular, cardiac, renal, endocrinologic, neurological, and psychomotor abnormalities, RSTS individuals can present with several gastrointestinal symptoms such as feeding difficulties, gastroesophageal reflux, and constipation. Currently, therapeutic strategies for RSTS involves a multi-disciplinary approach focusing mainly on symptomatic management. Here, we present a case of young-onset Barrett's esophagus in a patient with Rubinstein-Taybi syndrome.
Collapse
|
2
|
Saettini F, Herriot R, Prada E, Nizon M, Zama D, Marzollo A, Romaniouk I, Lougaris V, Cortesi M, Morreale A, Kosaki R, Cardinale F, Ricci S, Domínguez-Garrido E, Montin D, Vincent M, Milani D, Biondi A, Gervasini C, Badolato R. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome Patients. J Clin Immunol 2020; 40:851-860. [PMID: 32594341 DOI: 10.1007/s10875-020-00808-4] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 06/16/2020] [Indexed: 12/24/2022]
Abstract
Although recurrent infections in Rubinstein-Taybi syndrome (RSTS) are common, and probably multifactorial, immunological abnormalities have not been extensively described with only isolated cases or small case series of immune deficiency and dysregulation having been reported. The objective of this study was to investigate primary immunodeficiency (PID) and immune dysregulation in an international cohort of patients with RSTS. All published cases of RSTS were identified. The corresponding authors and researchers involved in the diagnosis of inborn errors of immunity or genetic syndromes were contacted to obtain up-to-date clinical and immunological information. Ninety-seven RSTS patients were identified. For 45 patients, we retrieved data from the published reports while for 52 patients, a clinical update was provided. Recurrent or severe infections, autoimmune/autoinflammatory complications, and lymphoproliferation were observed in 72.1%, 12.3%, and 8.2% of patients. Syndromic immunodeficiency was diagnosed in 46.4% of individuals. Despite the broad heterogeneity of immunodeficiency disorders, antibody defects were observed in 11.3% of subjects. In particular, these patients presented hypogammaglobulinemia associated with low B cell counts and reduction of switched memory B cell numbers. Immunoglobulin replacement therapy, antibiotic prophylaxis, and immunosuppressive treatment were employed in 16.4%, 8.2%, and 9.8% of patients, respectively. Manifestations of immune dysfunctions, affecting mostly B cells, are more common than previously recognized in patients with RSTS. Full immunological assessment is warranted in these patients, who may require detailed investigation and specific supportive treatment. Graphical Abstract.
Collapse
Affiliation(s)
- Francesco Saettini
- Pediatric Hematology Department, Fondazione MBBM, University of Milano Bicocca, via Pergolesi 33, 20900, Monza, Italy.
| | - Richard Herriot
- Immunology Department, Aberdeen Royal Infirmary, Aberdeen, UK
| | - Elisabetta Prada
- Department of Pathophysiology and Transplantation, Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
| | - Mathilde Nizon
- Service de Génétique Médicale, CHU de Nantes, 44000, Nantes, France.,Inserm, CNRS, l'institut du thorax, Universite de Nantes, 44000, Nantes, France
| | - Daniele Zama
- Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", Department of Pediatrics, Sant'Orsola Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy
| | - Antonio Marzollo
- Department of Women's and Children's Health, Pediatric Hemato-Oncology, University Hospital of Padova, Padova, Italy
| | - Igor Romaniouk
- Departamento de Nefrología, Hospital Universitario de Santiago, Santiago de Compostela, Spain
| | - Vassilios Lougaris
- Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, ASST-Spedali Civili of Brescia, University of Brescia, Brescia, Italy
| | - Manuela Cortesi
- Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, ASST-Spedali Civili of Brescia, University of Brescia, Brescia, Italy
| | - Alessia Morreale
- Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, ASST-Spedali Civili of Brescia, University of Brescia, Brescia, Italy
| | - Rika Kosaki
- Division of Medical Genetics, National Center for Child Health and Development, 2-10-1 Okura Setagaya-ku, Tokyo, 157-8535, Japan
| | | | - Silvia Ricci
- Pediatric Immunology, Meyer Children's University Hospital, Florence, Italy
| | | | - Davide Montin
- Division of Immunology and Rheumatology, Department of Paediatric Infectious Diseases, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
| | - Marie Vincent
- Service de Génétique Médicale, CHU de Nantes, 44000, Nantes, France.,Inserm, CNRS, l'institut du thorax, Universite de Nantes, 44000, Nantes, France
| | - Donatella Milani
- Department of Pathophysiology and Transplantation, Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
| | - Andrea Biondi
- Pediatric Hematology Department, Fondazione MBBM, University of Milano Bicocca, via Pergolesi 33, 20900, Monza, Italy
| | | | - Raffaele Badolato
- Departamento de Nefrología, Hospital Universitario de Santiago, Santiago de Compostela, Spain
| |
Collapse
|
3
|
Robertson J, Chadwick D, Baines S, Emerson E, Hatton C. Prevalence of Dysphagia in People With Intellectual Disability: A Systematic Review. INTELLECTUAL AND DEVELOPMENTAL DISABILITIES 2017; 55:377-391. [PMID: 29194030 DOI: 10.1352/1934-9556-55.6.377] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Dysphagia (feeding and swallowing disorder) is associated with serious health complications and psychosocial sequelae. This review summarizes international research relating to the prevalence of dysphagia in people with intellectual disability. Studies published from 1990 to July 2016 were identified using Medline, Cinahl, PsycINFO, Web of Science, email requests, and cross-citations. Twenty studies were identified. Dysphagia in people with intellectual disability appears to be associated with more severe levels of intellectual disability, comorbid cerebral palsy, and motor impairments. However, further research with representative samples of people with intellectual disability using adequate methods of assessment are required in order to provide more precise prevalence estimates and clarify factors that may be associated with dysphagia in this population.
Collapse
Affiliation(s)
- Janet Robertson
- Janet Robertson, Lancaster University, United Kingdom; Darren Chadwick, University of Wolverhampton, United Kingdom; Susannah Baines, Lancaster University, United Kingdom; Eric Emerson, Lancaster University, United Kingdom and University of Sydney, Australia; and Chris Hatton, Lancaster University, United Kingdom
| | - Darren Chadwick
- Janet Robertson, Lancaster University, United Kingdom; Darren Chadwick, University of Wolverhampton, United Kingdom; Susannah Baines, Lancaster University, United Kingdom; Eric Emerson, Lancaster University, United Kingdom and University of Sydney, Australia; and Chris Hatton, Lancaster University, United Kingdom
| | - Susannah Baines
- Janet Robertson, Lancaster University, United Kingdom; Darren Chadwick, University of Wolverhampton, United Kingdom; Susannah Baines, Lancaster University, United Kingdom; Eric Emerson, Lancaster University, United Kingdom and University of Sydney, Australia; and Chris Hatton, Lancaster University, United Kingdom
| | - Eric Emerson
- Janet Robertson, Lancaster University, United Kingdom; Darren Chadwick, University of Wolverhampton, United Kingdom; Susannah Baines, Lancaster University, United Kingdom; Eric Emerson, Lancaster University, United Kingdom and University of Sydney, Australia; and Chris Hatton, Lancaster University, United Kingdom
| | - Chris Hatton
- Janet Robertson, Lancaster University, United Kingdom; Darren Chadwick, University of Wolverhampton, United Kingdom; Susannah Baines, Lancaster University, United Kingdom; Eric Emerson, Lancaster University, United Kingdom and University of Sydney, Australia; and Chris Hatton, Lancaster University, United Kingdom
| |
Collapse
|
4
|
Robertson J, Chadwick D, Baines S, Emerson E, Hatton C. People with intellectual disabilities and dysphagia. Disabil Rehabil 2017; 40:1345-1360. [DOI: 10.1080/09638288.2017.1297497] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Janet Robertson
- Centre for Disability Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
| | - Darren Chadwick
- Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, United Kingdom
| | - Susannah Baines
- Centre for Disability Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
| | - Eric Emerson
- Centre for Disability Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
- Centre for Disability Research and Policy, University of Sydney, Sydney, Australia
| | - Chris Hatton
- Centre for Disability Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
| |
Collapse
|
10
|
Bonnard A, Auber F, Fourcade L, Marchac V, Emond S, Révillon Y. Vascular ring abnormalities: a retrospective study of 62 cases. J Pediatr Surg 2003; 38:539-43. [PMID: 12677561 DOI: 10.1053/jpsu.2003.50117] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND The authors analyzed clinical signs of vascular ring anomalies together with appropriate complementary examinations and factors predictive of outcome after surgical treatment. METHODS The authors reviewed the files of 62 patients with vascular ring abnormalities treated at Necker-Enfants Malades Hospital between January 1990 and January 2000, to analyze age at symptom onset, results of paraclinical examinations, the type of vascular ring abnormality, the surgical indications and type of surgery, and postoperative outcome. Outcomes were divided into 3 categories: cure, partial improvement, and no improvement. The chi2 test corrected with Fischer's Exact test was used for statistical analysis. RESULTS Vascular ring abnormalities were diagnosed at birth in 28% of cases and during the first year of life in 68%. Sixteen percent of patients had associated abnormalities. Recurrent pulmonary and bronchial infections occurred after one year of age. An esophagogram was done in 76% of cases and showed impression images. Endoscopy was done in 63% of cases and showed malacia in 41% of patients and stenosis in 51%. Fifty-eight children were treated surgically. The average hospital stay was 7.4 days. The average follow-up was 37.4 months (12 to 159 months). Complete improvement was obtained in 68% of cases, partial improvement in 17%, and no improvement in 15%. Preoperative malacia was more frequent in patients with partial improvement or no improvement. CONCLUSIONS Surgical treatment of congenital vascular ring abnormalities is effective and safe. Complications are rare. Prognostic factors include the quality of preoperative preparation of respiratory function, the type of abnormality, and the degree of malacia.
Collapse
Affiliation(s)
- A Bonnard
- Pediatric Surgery Unit, Necker Enfants-Malades, Paris, France
| | | | | | | | | | | |
Collapse
|